BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
March 1, 2010
View Archived Issues
IPO Activity Poised to Pop with Anthera, Aveo and Trius on Deck
It's been nearly a month since Ironwood Pharmaceuticals Inc. tested the biotech initial public offering waters, and now three more biotechs are queued up to price IPOs over the next three weeks. (BioWorld Today)
Read More
HCV Combo Approach Keeping Partner Hopes Bright for Idenix
Read More
'Clear and Testable Hypothesis' on Pediatric Asthma's Roots
Read More
Amicus Adds $18.5M Publicly for Phase III Amigal Program
Read More
Collins: NIH Funding Boosts Economy, Spurs Job Growth
Read More
Move Over, Cerezyme; Shire's Vpriv Gets Official FDA Nod
Read More
Other News To Note
Read More
Vital Signs for March 1, 2010
Read More
Clinic Roundup
Read More
Bench Press
Read More